# FDA Inspection 1218331 - AstraZeneca Pharmaceuticals LP - September 19, 2023

Source: https://www.globalkeysolutions.net/records/fda_inspections/astrazeneca-pharmaceuticals-lp/f66f66c2-0f6a-4aa1-972a-c17574142886/
Source feed: FDA_Inspections

> FDA Inspection 1218331 for AstraZeneca Pharmaceuticals LP on September 19, 2023. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1218331
- Company Name: AstraZeneca Pharmaceuticals LP
- Inspection Date: 2023-09-19
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 965123 - 2016-01-28](https://www.globalkeysolutions.net/api/records/fda_inspections/astrazeneca-pharmaceuticals-lp/591ca477-34f4-4276-ac90-cbdfea8fdf2d/)
- [FDA Inspection 853863 - 2013-10-25](https://www.globalkeysolutions.net/api/records/fda_inspections/astrazeneca-pharmaceuticals-lp/abe000c7-f8bd-45af-b0af-2bb08474e3ed/)
- [FDA Inspection 798609 - 2012-09-13](https://www.globalkeysolutions.net/api/records/fda_inspections/astrazeneca-pharmaceuticals-lp/92cc88df-ce4e-4f65-a593-a36f9339c932/)
- [FDA Inspection 751470 - 2011-10-28](https://www.globalkeysolutions.net/api/records/fda_inspections/astrazeneca-pharmaceuticals-lp/5d401b01-20f7-49dd-b629-fc4aeae2f2cf/)
- [FDA Inspection 741276 - 2011-08-12](https://www.globalkeysolutions.net/api/records/fda_inspections/astrazeneca-pharmaceuticals-lp/49b21f43-de91-4fdb-b14b-59e59ab1d9c8/)

Company: https://www.globalkeysolutions.net/companies/astrazeneca-pharmaceuticals-lp/80a406f0-7f62-4d81-841e-7f01c9950c06

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c